Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014
Volume10
Issue 5

Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association

Author(s):

Melanie Sena

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

Johnson & Johnson reported its affiliate Janssen Pharmaceutical NV has entered into a collaboration with the Stiching International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to the company’s anti-tuberculosis medicine. This public-private partnership was established by the newly formed Janssen Global Public Health, to help improve overall public health.

More than 130 low- and middle-income countries outside of the US will now be able to obtain this new anti-tuberculosis medicine through the procurement processes of GDF and its agent, the IDA.

Source: Johnson & Johnson

Articles in this issue
Web-Kurt-Lumsden-842476-1408522400909.png
Using eClinical Systems for Supply-Chain Management
Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association
Wechsler_Jill-842477-1408522399381.jpg
FDA and Industry Take Action for a More Secure Drug Supply Chain
Packaging Becomes Enabler for Biopharmaceuticals
Bristol-Myers Squibb Named First on 2014 Best Corporate Citizens List
Azzur Group and BioSPEQ Announce Merger
Eli Lilly Launches Second Education Program for Medical Students
Global Instability Impacts Brazil's Pharma Market
Global Instability Impacts Brazil's Pharma Market
peters_rita-842486-1408522392330.jpg
US Biopharma Worries About Losing Lead in Innovation
Eric_Langer_Headshot-842478-1408522397462.jpg
Outsourcing Remains Strong In Traditional Areas
Process Design Is Critical for Commercial Manufacture of HPAPIs
Process Design Is Critical for Commercial Manufacture of HPAPIs
Novartis Publishes eBook of Meningococcal Disease Survivors
Gallus BioPharmaceuticals Enters Agreement with Omni Bio Pharmaceutical
Colorcon Opens Major Facility in India
Capsugel Enters Agreement with Chiasma to Manufacture Oral Octreotide Acetate

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content
Futuristic health tech. A smartwatch projects a holographic health dashboard, providing real-time body analytics and vital signs monitoring anytime, anywhere. | Image Credit: © woravut - stock.adobe.com
August 5th 2025

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

Patrick Lavery
The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 5th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
White House | Image Credit: © Zack Frank - stock.adobe.com
August 5th 2025

Trump Sends Letters to 17 Leading Pharma Companies Outlining Most-Favored-Nation Drug Pricing Protocol

Patrick Lavery
If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
August 5th 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 5th 2025

FDA Changes Opioid Pain Medication Labeling Requirements

Susan Haigney
The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse and addiction.
Kratom or Mitragyna speciosa on natural background. | Image Credit: © wasanajai - stock.adobe.com
August 5th 2025

FDA Seeks Scheduling Action to Control Harmful Kratom Plant Byproduct

Patrick Lavery
7-OH and the leaf of the kratom plant are not analogous, but as the former is a derivative of the latter, it has opioid-like qualities that make its susceptibility to abuse concerning.